The current state of cardiology in China

International Journal of Cardiology

Volumn 96, Issue 3, 2004, Pages 425-439

  Cheng, Tsung O ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiology; China; West

Indexed keywords

ARTICLE; CHINA; CORONARY ARTERY DISEASE; DIET; HEART INFARCTION; HUMAN; INCIDENCE; LIFESTYLE; PRIORITY JOURNAL;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR SURGICAL PROCEDURES; CHINA; DIET; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; OBESITY; PUBLISHING; PULMONARY EMBOLISM; SMOKING;

EID: 4143128917     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.10.011     Document Type: Article

References (102)

1. Cheng T.O. Changes in China. N Engl. J. Med. 287:1972;259
2. Cheng T.O. Acupuncture anesthesia. Science. 179:1973;521
3. Cheng T.O. A view of modern Chinese medicine. Observations by a Shanghai-born physician during his recent visit after 22 years of absence. Ann. Intern. Med. 78:1973;285-290
4. Cheng T.O. Medicine in modern China. J. Am. Geriatr. Soc. 21:1973;289-313
5. Cheng T.O. Cardiovascular diseases. Quinn J. China medicine as we saw it. 1974;261-288 The Fogarty International Center, Bethesda
6. Cheng T.O., Paul D. White lecture - Cardiology in People's Republic of China. Russek H.I. New horizons in cardiovascular practice. 1975;1-27 University Park Press, Baltimore
7. Cheng T.O. Acupuncture anesthesia for open heart surgery. Am. J. Cardiol. 36:1975;411
8. Cheng T.O. Cardiology in People's Republic of China in 1977. Chest. 74:1978;209-211
9. Cheng T.O. Cardiology in China revisited. Am. J. Cardiol. 42:1978;700-702
10. Cheng T.O. Barefoot doctors. Postgrad. Med. 70(5):1981;41
11. Cheng T.O. Cardiovascular disease in China. Nat. Med. 4:1998;1209-1210
12. Cheng T.O. Coronary heart disease in China. Hosp. Med. 60:1999;456
13. Cheng T.O. Price of modernization of China. Circulation. 103:2001;e132
14. Snapper I Chinese lessons to western medicine. 1941;160 Interscience, New York
15. Phillips M.R., Li X., Zhang Y. Suicide rates in China 1995-99. Lancet. 359:2002;835-840
16. Sung J.J.Y., Wong L.K.S., Li P.K.T., Sanderson J., Kwok T.C.Y. Principles and practice of clinical medicine in Asia. Treating the Asian patient. 2002;35 Lippincott, Williams and Wilkins, Philadelphia
17. McGregor R. China swallows fast food at an ever more rapid rate. Financial Times. 2003;12. [January 20]
18. Winslow R. Risk of having heart disease soars in China. Wall Str. J. 2002;B1. [April 25]
19. Leung S. Experts differ on healthiness of 'fast' salad. Wall Str. J. 2003;B1. [May 8]
20. Du S., Lu B., Zhai F., Popkin B.M. A new stage of the nutrition transition in China. Public Health Nutr. 5(1A):2002;169-174
21. Wang X., Fan Z., Huang J., Su S., Yu Q., Zhao J., et al. Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population. Arterioscler. Thromb. Vasc. Biol. 23:2003;328-334
22. Li J., Chen M., Wang S., Deng J., Zeng P., Hou L. A long-term follow-up study of serum lipids and coronary heart disease in the elderly. Chin. J. Cardiol. 30:2002;647-650
23. Zhao D. Epidemiologic study of blood lipids in the Chinese population. Chin. J. Cardiol. 31:2003;74-78
24. Cheng T.O. The international textbook of cardiology. 1987;12 Pergamon, New York
25. Chen G.W., Cheng T.O. The textbook of modern cardiology. 2nd ed.:2002;1546 Hunan Science and Technology Press, China
26. Chen Z., Peto R., Collins R., MacMahon S., Lu J., Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ. 303:1991;276-282
27. Chen K. New craze seizes China's consumers: a glass of milk. Wall Str. J. 2003;A1. [February 28]
28. Dwyer T., Emmanuel S.C., Janus E.D., Wu Z., Hynes K.L., Zhang C. The emergence of coronary heart disease in populations of Chinese descent. Atherosclerosis. 67:2003;303-310
29. Luo Z. Obesity: a warning to Chinese children. Beijing Rev. 45(26):2002;14-16
30. Popkin B.M., Doak C.M. The obesity epidemic is a worldwide phenomenon. Nutr. Rev. 56:1998;106-114
31. Cheng T.O. Fast food and obesity in China. J. Am. Coll. Cardiol. 42:2003;773
32. Ma G.S., Li Y.P., Hu X.Q., Ma W.J., Wu J. Effect of television viewing on pediatric obesity. Biomed. Environ. Sci. 15:2002;291-297
33. Torpy J.M., Lynm C., Glass R.M. JAMA patient page. Obesity. JAMA. 289:2003;1880
34. Yanovski J.A., Yanovski S.Z. Treatment of pediatric and adolescent obesity. JAMA. 289:2003;1851-1853
35. Shi H., Zhu Z. Advances in research on hypertension and obesity. Program of National Congress on Prevention and Treatment of Obesity, Suzhou, China. 2003;36-41
36. Li G., Chen X., Jang Y., Wang J., Xing X., Yang W., et al. Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population. Obes. Rev. 3:2002;167-172
37. Chinese Medical Association Subsection of Cardiovascular Disease, Chinese Journal of Cardiology Editorial Board Highlights of the Second National Conference on Dyslipidemia. Chin. J. Cardiol. 30:2002;643-646
38. Jia W.P., Xiang K.S., Chen L., Lu J.X., Wu Y.M. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes. Rev. 3:2002;157-165
39. Zhou B., Wu Y., Yang J., Li Y., Zhang H., Zhao L. Overweight is an independent risk factor for cardiovascular disease in Chinese populations. Obes. Rev. 3:2002;147-156
40. Cheng T.O. An obesity epidemic in modern China. Am. J. Cardiol. 88:2001;721-722
41. Zhai F., Fu D., Du S., Ge K., Chen C., Popkin B.M. What is China doing in policy-making to push back the negative aspects of the nutrition transition? Public Health Nutr. 5(1A):2002;269-273
42. National Conference on Prevention and Treatment of Obesity to be held in Suzhou. Nat. Med. J. China. 82:2002;1631
43. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N. Engl. J. Med. 348:2003;1625-1638
44. Cheng T.O. Smoking and diabetes in Chinese men. Postgrad. Med. J. 77:2001;551
45. Cheng T.O. Teenage smoking in China. J. Adolesc. 22:1999;607-620
46. Cheng T.O. Smoking and health. Can. Med. Assoc. J. 144:1991;630-631
47. Cheng T.O. Do photographs lie? Smoking in China. Gerontologist. 32:1992;274
48. Lam T.H., He Y., Li L.S., He S.F., Liang B.Q. Mortality attributable to cigarette smoking in China. JAMA. 278:1997;1505-1508
49. He Y., Lam T.H. A review on studies of smoking and coronary heart disease in China and Hong Kong. Chin. Med. J. 112:1999;3-8
50. Luo L., Luan R.S., Yuan P. Meta-analysis of risk factors on hypertension in China. Chin. J. Epidemiol. 24:2003;50-53
51. WHA approves historic tobacco accord. Lancet. 361:2003;1793
52. Yu M., Gao R., Chen J., Yang Y., Qin X., Qiao S., et al. Complications in selective coronary arteriography: analysis of 9196 cases. Nat. Med. J. China. 83:2003;91-95
53. Johnson L.W., Lozner E.C., Johnson S., Krone R., Pichard A.D., Vetrovec G.W., et al. Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions: I. Results and complications. Catheter. Cardiovasc. Diagn. 17:1989;5-10
54. Gao R. Furthering the healthy development of percutaneous coronary interventions in China. Chin. J. Cardiol. 30:2002;705-706
55. Section of Interventional Cardiology, Chinese Society of Cardiology, Editorial Office of Chinese Journal of Cardiology: A data analysis of the Third National Coronary Intervention Registry Chin. J. Cardiol. 30:2002;719-723
56. Fleisher L.A., Barash P.G. Treatment of coronary artery disease in the year 2003. J. Cardiothorac. Vasc. Anesth. 17:2003;258-259
57. Tan H.Q., Liang Y., Zhu J., Liu L.S. Clinical characteristics of acute ischemic syndrome in China. Chin. Med. J. 115:2002;1123-1126
58. Chen C., Cheng T.O. for the Multicenter Study Group Percutaneous balloon mitral valvuloplasty using Inoue technique: a multicenter study of 4832 patients in China. Am. Heart J. 129:1995;1197-1204
59. Cheng T.O., Holmes D.R. Jr. Percutaneous balloon mitral valvuloplasty by the Inoue balloon technique: the procedure of choice for treatment of mitral stenosis. Am. J. Cardiol. 81:1998;624-628
60. Cheng T.O., Chen C.R. Late results of percutaneous balloon mitral valvuloplasty: the Chinese experience. Circulation. 102:2000;e18
61. Li Z.Q., Cheng T.O., Zhang W.W., Qiao S.B., Zhao L.Y., Jin Y.Z., Guan R.M., Li L. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. The Chinese experience in 119 patients from a single center. Int. J. Cardiol. 93:2004;197-202
62. Li Z.Q., Cheng T.O., Liu L., Jin Y.Z., Zhang M., Guan R.M., et al. Experimental study of relationship between intracoronary alcohol injection and the size of resultant myocardial infarct. Int. J. Cardiol. 91:2003;93-96
63. Hsieh H., Yu T.J., Yang W.C., Chu S.S., Lai M.K. The gift of life from prisoners sentenced to death: preliminary report. Transplant. Proc. 24:1992;1335-1336
64. Jia W., Li F., Cui T., Wang H. An investigation on the misdiagnosis of pulmonary embolism in China. Chin. J. Cardiol. 30:2002;406-409
65. Zhai Z., Wang C. Nomenclature and definition of pulmonary thromboembolism. Nat. Med. J. China. 82:2002;1574-1575
66. Guidelines to the diagnosis and treatment of pulmonary thromboembolism. Chin. Tuberculosis Respir. J. 24:2001;259-264
67. Holden J.L. Preface. The role of the media in a market economy (report by R.L. Keatley). China Policy Series No. 19. 2003;National Committee on United States-China Relations, New York, NY. [February]
68. Smith R. Chinese medical journals; getting in touch. Chinese editors and medical journals have much to offer. BMJ. 309:1994;74
69. Zhang H., Wang F., Li C. A preliminary study of reference citations of foreign journals in articles published in the Chinese Journal of Cardiology. Chin. J. Cardiol. 30:2002;615
70. Moriearty P.L., Chen S.B. International access to the Chinese medical literature through MEDLINE. Chin. Med. J. 106:1993;243-249
71. Cheng T.O. The Chinese last name. J. Thorac. Cardiovasc. Surg. 96:1988;832
72. Cheng T.O. What's in a name - the Chinese name? Angiology. 40:1989;324
73. Cheng T.O. Word order: oriental or occidental? Texas Heart Inst. J. 16:1989;121
74. Cheng T.O. Chinese name. Prehosp. Disaster Med. 8:1993;268-269
75. Cheng T.O. Use of surnames to identify individuals of Chinese ancestry. Am. J. Epidemiol. 140:1994;76
76. Cheng T.O. Chinese last name comes first. Int J. Cardiol. 49:1995;94
77. Mervis J. China's unique environment favors large intervention trials. Science. 270:1995;1149-1151
78. Ross A.M., Gao R., Coyne K.S., Chen J., Yao K., Yang Y., et al. A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial. Am. Heart J. 142:2001;244-247
79. Cheng T.O. Acronyms of clinical trials in cardiology - 1994. Am. J. Cardiol. 74:1994;79-94
80. Cheng T.O. Acronymophilia: the exponential growth of the use of acronyms should be resisted. BMJ. 309:1994;683-684
81. Cheng T.O. Acronymania, acronymophilia and acronymophobia. Br. J. Cardiol. 5:1998;624-625
82. Cheng T.O. Acronyms of clinical trials in cardiology - 1998. Am. Heart J. 137:1999;726-765
83. Cheng T.O., Julian D. Acronyms of cardiologic trials - 2002. Int. J. Cardiol. 91:2003;261-351
84. Wang Q., Zhang B. Research design and statistical methods in Chinese medical journals. JAMA. 280:1998;283-285
85. Xia J., Tang D., Xia K., Tan S. The achievements of medical genetic research in China during the past 50 years. Chin. Med. J. 112:1999;956-958
86. Li Y.Q. China launches genome project. Nature. 365:1993;200
87. Cyranoski D. A great leap forward. Nature. 410:2001;10-12
88. Genetic map. Beijing Rev. 44(32):2001;4
89. Chen G.W., Cheng T.O. The textbook of modern cardiology. 2nd ed.:2002;1527-1530 Hunan Science and Technology Press, China
90. Peng S., Peng J., Gong W. Relationship between apolipoprotein E gene polymorphism and myocardial infarction or its action on clinical courses. Int. J. Cardiovasc. Med. 5:2003;26-28
91. Zhang Z., Cheng T.O., Zhang Y. A textbook on congestive heart failure. Beijing, China: Science and Technology Publishers, 2003, pp. 3-48, 572-585, 972-973.
92. Normile D. From standing start to sequencing superpower. Science. 296:2002;36-39
93. Cheng T.O. Warfarin danshen interaction. Ann. Thorac. Surg. 67:1999;894
94. Cheng T.O. Warning about a medicinal herb. Hosp. Pract. 34(10):1999;23
95. Cheng T.O. Herbal remedies. Am. Fam. Phys. 60:1999;1661
96. Cheng T.O. Interaction of herbal medicine with coumadin. J. Emerg. Med. 18:2000;122
97. Cheng T.O. Ginseng-warfarin interaction. Am. Coll. Cardiol. Curr. J. Rev. 9(1):2000;84
98. Cheng T.O. Comment: drug-herb interaction. Ann. Pharmacother. 35:2001;124
99. Cheng T.O. Herbal interactions with cardiac drugs. Arch. Intern. Med. 160:2000;870-871
100. Cheng T.O. St. John's Wort interaction with digoxin. Arch. Intern. Med. 160:2000;2548
101. Cheng T.O. Interaction of herbal drugs with digoxin. J. Am. Coll. Cardiol. 40:2002;838-839
102. Cheng T.O. Panax (Ginseng) is not a panacea. Arch. Intern. Med. 160:2000;3329